Perspectives

Angel investing is a tricky game. Supporting a startup just getting off the ground takes a lot of work. But after several years spent as a venture capitalist in the Bay Area, Susan Preston, now the managing member at Seattle’s SeaChange Fund, returned to the Pacific Northwest with an idea for how to spot sound […]

Every patient’s cancer is unique and every patient responds to cancer drugs differently. But right now, all patients with the same kind of cancer are treated with the same drugs. SEngine Precision Medicine is hoping to change that with new platform, called PARIS, that grows and analyzes a patient’s cancer cells to figure out which drugs […]

We’re proud to have cultivated the speaking engagement for Phase Genomics. CEO Ivan Liachko will present on the convergence of technology and the life sciences on June 12th in Seattle, alongside other biotech innovators such as Adaptive Biotechnologies and Silverback Therapeutics. Find the details and join us here: https://www.xconomy.com/whats-hot-in-seattle-biotech/speakers/    

Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers Read the story here

Female Founders Alliance Founder, Leslie Feinzaig speaks with KOMO 4’s Mary Nam about the inaugural Champion Awards honoring advocates for women founders in tech, launching Female Founders Alliance and the rapid international growth of the organization. s2s PR happy to help make the media opportunity a reality. See the entire clip from the February 2018 appearance […]

Read SEngine Precision Medicine CEO Dr. Carla Grandori’s article about the future of personalize cancer treatment, Young Lions https://www.linkedin.com/pulse/young-lions-harnessing-next-generation-technologies-carla/?published=t

See Founder Jamien McCullum speak about the future of the trust-economy and Vermouth on FOX Q13

Read the article as SEngine as emerges as the first Functional Precision Medicine lab to receive CLIA certification